BC
KURA icon

Boxer Capital’s Kura Oncology KURA Stock Holding History

Boxer Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000,000
Closed -$19.5M – 26
2024
Q3 		$19.5M Hold
1,000,000
– – 0.96% 28
2024
Q2 		$20.6M Hold
1,000,000
– – 1.08% 27
2024
Q1 		$21.3M Buy
+1,000,000
New +$19.4M 1.05% 28
2021
Q4 		– Sell
-1,050,289
Closed -$19.7M – 80
2021
Q3 		$19.7M Hold
1,050,289
– – 0.69% 41
2021
Q2 		$21.9M Hold
1,050,289
– – 0.77% 39
2021
Q1 		$29.7M Hold
1,050,289
– – 1.01% 31
2020
Q4 		$34.3M Hold
1,050,289
– – 1.1% 25
2020
Q3 		$32.2M Buy
1,050,289
+205,500
+24% +$4.54M 1.11% 23
2020
Q2 		$13.8M Hold
844,789
– – 0.61% 40
2020
Q1 		$8.41M Hold
844,789
– – 0.57% 41
2019
Q4 		$11.6M Hold
844,789
– – 0.66% 36
2019
Q3 		$12.8M Hold
844,789
– – 0.93% 26
2019
Q2 		$16.6M Hold
844,789
– – 1.43% 20
2019
Q1 		$14M Hold
844,789
– – 1.62% 17
2018
Q4 		$11.9M Hold
844,789
– – 1.47% 16
2018
Q3 		$14.8M Hold
844,789
– – 1.64% 15
2018
Q2 		$15.4M Hold
844,789
– – 1.74% 18
2018
Q1 		$15.8M Hold
844,789
– – 1.69% 18
2017
Q4 		$12.9M Hold
844,789
– – 2.36% 12
2017
Q3 		$12.6M Buy
844,789
+311,538
+58% +$2.92M 2.88% 10
2017
Q2 		$4.96M Hold
533,251
– – 1.18% 17
2017
Q1 		$4.69M Hold
533,251
– – 1.03% 16
2016
Q4 		$3.15M Hold
533,251
– – 1.22% 14
2016
Q3 		$3.33M Sell
533,251
-100,441
-16% -$509K 1.49% 18
2016
Q2 		$1.72M Sell
633,692
-11,993
-2% -$37.3K 1.52% 17
2016
Q1 		$2.62M Sell
645,685
-8,910
-1% -$42.3K 2.56% 11
2015
Q4 		$5.5M Buy
+654,595
New +$5.15M 4.75% 5

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boxer Capital's KURA Position: Q4 2024 in Review

Boxer Capital sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 1,000,000 shares — an estimated $19.5M sold.

Boxer Capital first reported a position in KURA in Q4 2015 and held it in 27 quarters. The position peaked at $34.3M in Q4 2020. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • Boxer Capital reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 1,000,000 Kura Oncology shares in Q4 2024, an estimated $19.5M.
  • Boxer Capital first reported a position in Kura Oncology in Q4 2015 and held it in 27 quarters.
  • Boxer Capital's Kura Oncology position peaked at $34.3M in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.